Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07633184

Lung Ultrasound Score for Early Prediction of Bronchopulmonary Dysplasia in Preterm Newborns

Conditions: Bronchopulmonary Dysplasia

Sex: All
Ages: N/A – 31 Weeks
Healthy volunteers: No
Enrollment: 40
Sponsor: Azienda USL Reggio Emilia - IRCCS

Location: Neonatology and Neonatal Intensive Care Unit AOU Policlinico Modena Modena

Summary

Bronchopulmonary dysplasia (BPD) is one of the most common and severe complications of extreme prematurity, affecting approximately 40% of infants born before 28 weeks of gestation. Despite advances in neonatal care and improved survival rates for extremely preterm infants, the incidence of BPD remains high. BPD is associated with significant short- and long-term morbidity, including chronic respiratory impairment, pulmonary hypertension, recurrent respiratory infections, and neurodevelopmental sequelae. Current diagnosis of BPD is based on the need for respiratory support at 36 weeks postmenstrual age, limiting opportunities for early therapeutic intervention. Since structural lung injury may become irreversible within the first weeks of life, the identification of reliable early predictors of BPD is a major clinical priority. Lung ultrasound (LUS) is a non-invasive, radiation-free, bedside imaging technique increasingly used in neonatal intensive care units. The Lung Ultrasound Score (LUS) provides a quantitative assessment of lung aeration and has demonstrated utility in predicting several neonatal respiratory outcomes. Recent studies suggest that both LUS and pleural line abnormalities detected during the first weeks of life may be associated with the subsequent development of BPD, although evidence remains heterogeneous and no universally validated predictive method is currently available.

Eligibility Criteria

Inclusion Criteria: * born at less than 32 weeks' gestational age; * born in the Neonatology Department of one of the centres participating in the study or transferred there from another hospital within the first week of life; * parents/guardians have signed an informed consent form regarding the inclusion of thenewborn in the study and consent to the processing of personal data Exclusion Criteria: * major malformations,chromosomal abnormalities, congenital chest wall deformities, congenital heart defects, pulmonary hypoplasia, diaphragmatic hernia, suspected muscular dystrophy or neurological disorders that may impair lung development; * receipt of palliative care from birth; * death before 36 weeks' gestational age; * inability to perform a chest ultrasound or to adequately examine all 6 lung fields at both 7 (+/-1) and 14 (+/-2) days for any intervening reason; * inability to collect the data necessary to formulate a diagnosis of BPD within the duration of the study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07633184). StuddyBuddy aggregates publicly available trial information.